Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy

被引:136
作者
Blankenberg, FG
Katsikis, PD
Storrs, RW
Beaulieu, C
Spielman, D
Chen, JY
Naumovski, L
Tait, JF
机构
[1] STANFORD UNIV,SCH MED,DEPT RADIOL,STANFORD,CA 94305
[2] STANFORD UNIV,SCH MED,DEPT GENET,STANFORD,CA 94305
[3] STANFORD UNIV,SCH MED,DEPT PEDIAT,STANFORD,CA 94305
[4] STANFORD UNIV,SCH HUMANITIES & SCI,DEPT CHEM,STANFORD,CA 94305
[5] UNIV WASHINGTON,DEPT LAB MED,SEATTLE,WA 98195
关键词
D O I
10.1182/blood.V89.10.3778.3778_3778_3786
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Quantification of apoptotic cell death in vivo has become an important area of investigation in patients with acute lymphoblastic leukemia (ALL). We have devised a noninvasive analytical method to estimate the percentage of apoptotic lymphoblasts in doxorubicin-treated Jurkat T-cell ALL cultures, using proton nuclear magnetic resonance spectroscopy (H-1 NMR). We have found that the ratio of the methylene (CH2) resonance (at 1.3 ppm) to the methyl (CH3) resonance (at 0.9 ppm) signal intensity, as observed by H-1 NMR, is directly proportional to the percentage of apoptotic lymphoblasts in vitro. The correlation between the CH2/CH3 signal intensity ratio and the percentage of apoptotic lymphoblasts was optimal 24 to 28 hours after doxorubicin treatment (r(2) = .947, N = 27 samples), There was also a direct temporal relationship between an increase in the CH2/ CH3 signal intensity ratio and the onset of apoptosis as detected by nuclear morphologic analysis, fluorescein-annexin V flow cytometry, and DNA gel electrophoresis. Thin-layer chromatography confirmed that a dynamic and/or compositional change of the plasma membrane, rather than increases in lipase activity or fatty acid production, appears to account for the increase in the CH2/CH3 signal intensity ratio during apoptosis. H-1 NMR may have clinical utility for the early noninvasive assessment of chemotherapeutic efficacy in patients with ALL. (C) 1997 by The American Society of Hematology.
引用
收藏
页码:3778 / 3786
页数:9
相关论文
共 36 条
[1]  
ASSELIN BL, 1989, CANCER RES, V49, P4363
[2]   INVIVO MEASUREMENTS OF BONE-MARROW CELLULARITY USING VOLUME-LOCALIZED PROTON NMR-SPECTROSCOPY [J].
BALLON, D ;
JAKUBOWSKI, A ;
GABRILOVE, J ;
GRAHAM, MC ;
ZAKOWSKI, M ;
SHERIDAN, C ;
KOUTCHER, JA .
MAGNETIC RESONANCE IN MEDICINE, 1991, 19 (01) :85-95
[3]  
Blankenberg FG, 1996, BLOOD, V87, P1951
[4]   APOPTOSIS AND A REINVESTIGATION OF THE BIOLOGIC BASIS FOR CANCER-THERAPY [J].
DAMICO, AV ;
MCKENNA, WG .
RADIOTHERAPY AND ONCOLOGY, 1994, 33 (01) :3-10
[5]   APOPTOSIS IN ANTITUMOR STRATEGIES - MODULATION OF CELL-CYCLE OR DIFFERENTIATION [J].
DARZYNKIEWICZ, Z .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, 58 (02) :151-159
[6]  
DARZYNKIEWICZ Z, 1994, METHOD CELL BIOL, V41, P15
[7]   ANALYSIS AND DISCRIMINATION OF NECROSIS AND APOPTOSIS (PROGRAMMED CELL-DEATH) BY MULTIPARAMETER FLOW-CYTOMETRY [J].
DIVE, C ;
GREGORY, CD ;
PHIPPS, DJ ;
EVANS, DL ;
MILNER, AE ;
WYLLIE, AH .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1133 (03) :275-285
[8]   Very delayed infarction after mild focal cerebral ischemia: A role for apoptosis? [J].
Du, C ;
Hu, R ;
Csernansky, CA ;
Hsu, CY ;
Choi, DW .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1996, 16 (02) :195-201
[9]  
FADOK VA, 1992, J IMMUNOL, V149, P4029
[10]  
FADOK VA, 1993, J IMMUNOL, V151, P4274